Characterization/NN
of/IN
5'/JJ
end/NN
of/IN
human/JJ
thromboxane/NN
receptor/NN
gene/NN
./.
=====
Organizational/JJ
analysis/NN
and/CC
mapping/NN
of/IN
protein/NN
kinase/NN
C/NN
--/:
responsive/JJ
elements/NNS
regulating/VBG
expression/NN
in/IN
platelets/NNS
./.

Platelet/NN
thromboxane/NN
receptors/NNS
are/VBP
acutely/RB
and/CC
reversibly/RB
upregulated/VBN
after/IN
acute/JJ
myocardial/JJ
infarction/NN
./.
=====
To/TO
determine/VB
if/IN
platelet/NN
thromboxane/NN
receptors/NNS
are/VBP
under/IN
transcriptional/JJ
control/NN
,/,
we/PRP
isolated/VBD
and/CC
characterized/VBD
human/JJ
genomic/JJ
DNA/NN
clones/NNS
containing/VBG
the/DT
5'/JJ
flanking/JJ
region/NN
of/IN
the/DT
thromboxane/NN
receptor/NN
gene/NN
./.
=====
The/DT
exon-intron/JJ
structure/NN
of/IN
the/DT
5'/JJ
portion/NN
of/IN
the/DT
thromboxane/NN
receptor/NN
gene/NN
was/VBD
determined/VBN
initially/RB
by/IN
comparing/VBG
the/DT
nucleotide/NN
sequence/NN
of/IN
the/DT
5'/JJ
flanking/JJ
genomic/JJ
clone/NN
with/IN
that/DT
of/IN
a/DT
novel/JJ
human/JJ
uterine/NN
thromboxane/NN
receptor/NN
cDNA/NN
that/WDT
extended/VBD
the/DT
mRNA/NN
141/CD
bp/NN
further/RBR
upstream/RB
than/IN
the/DT
previously/RB
identified/VBN
human/JJ
placental/JJ
cDNA/NN
./.
=====
A/DT
major/JJ
transcription/NN
initiation/NN
site/NN
was/VBD
located/JJ
in/IN
three/CD
human/JJ
tissues/NNS
approximately/RB
560/CD
bp/NN
upstream/JJ
from/IN
the/DT
translation/NN
initiation/NN
codon/NN
and/CC
380/CD
bp/NN
upstream/JJ
from/IN
any/DT
previously/RB
identified/VBN
transcription/NN
initiation/NN
site/NN
./.
=====
The/DT
thromboxane/NN
receptor/NN
gene/NN
has/VBZ
neither/CC
a/DT
TATA/NN
nor/CC
a/DT
CAAT/NN
consensus/NN
site/NN
./.
=====
Promoter/NN
function/NN
of/IN
the/DT
5'/JJ
flanking/JJ
region/NN
of/IN
the/DT
thromboxane/NN
receptor/NN
gene/NN
was/VBD
evaluated/VBN
by/IN
transfection/NN
of/IN
thromboxane/NN
receptor/NN
gene/NN
promoter/chloramphenicol/NN
acetyltransferase/NN
(/(
CAT/NN
)/)
chimera/NN
plasmids/NNS
into/IN
platelet-like/JJ
K562/NN
cells/NNS
./.
=====
Thromboxane/NN
receptor/NN
promoter/NN
activity/NN
,/,
as/IN
assessed/VBN
by/IN
CAT/NN
expression/NN
,/,
was/VBD
relatively/RB
weak/JJ
but/CC
was/VBD
significantly/RB
enhanced/VBN
by/IN
phorbol/NN
ester/NN
treatment/NN
./.
=====
Functional/JJ
analysis/NN
of/IN
5'/JJ
deletion/NN
constructs/NNS
in/IN
transfected/VBN
K562/NN
cells/NNS
and/CC
gel/NN
mobility/NN
shift/NN
localized/VBD
the/DT
major/JJ
phorbol/NN
ester-responsive/JJ
motifs/NNS
in/IN
the/DT
thromboxane/NN
receptor/NN
gene/NN
promoter/NN
to/TO
a/DT
cluster/NN
of/IN
activator/NN
protein-2/NN
(/(
AP-2/NN
)/)
binding/NN
consensus/NN
sites/NNS
located/JJ
approximately/RB
1.8/CD
kb/NN
5'/JJ
from/IN
the/DT
transcription/NN
initiation/NN
site/NN
./.
=====
These/DT
studies/NNS
are/VBP
the/DT
first/JJ
to/TO
determine/VB
the/DT
structure/NN
and/CC
organization/NN
of/IN
the/DT
5'/JJ
end/NN
of/IN
the/DT
thromboxane/NN
receptor/NN
gene/NN
and/CC
demonstrate/VBP
that/IN
thromboxane/NN
receptor/NN
gene/NN
expression/NN
can/MD
be/VB
regulated/VBN
by/IN
activation/NN
of/IN
protein/NN
kinase/NN
C/NN
via/IN
induction/NN
of/IN
an/DT
AP-2-like/JJ
nuclear/JJ
factor/NN
binding/VBG
to/TO
upstream/JJ
promoter/NN
elements/NNS
./.
=====
These/DT
findings/NNS
strongly/RB
suggest/VBP
that/IN
the/DT
mechanism/NN
for/IN
previously/RB
described/VBN
upregulation/NN
of/IN
platelet/NN
thromboxane/NN
receptors/NNS
after/IN
acute/JJ
myocardial/JJ
infarction/NN
is/VBZ
increased/VBN
thromboxane/NN
receptor/NN
gene/NN
transcription/NN
in/IN
platelet-progenitor/JJ
cells/NNS
./.